Charles Schwab’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.08M | Buy |
601,447
+53,433
| +10% | +$274K | ﹤0.01% | 2525 |
|
|
2025
Q1 | $751K | Buy |
548,014
+34,585
| +7% | +$47.4K | ﹤0.01% | 2947 |
|
|
2024
Q4 | $1.59M | Buy |
513,429
+26,192
| +5% | +$80.9K | ﹤0.01% | 2747 |
|
|
2024
Q3 | $3.75M | Buy |
487,237
+76,540
| +19% | +$589K | ﹤0.01% | 2507 |
|
|
2024
Q2 | $3.52M | Buy |
410,697
+31,220
| +8% | +$268K | ﹤0.01% | 2513 |
|
|
2024
Q1 | $3.01M | Buy |
379,477
+10,411
| +3% | +$82.7K | ﹤0.01% | 2474 |
|
|
2023
Q4 | $3.65M | Buy |
369,066
+1,709
| +0.5% | +$16.9K | ﹤0.01% | 2440 |
|
|
2023
Q3 | $4.14M | Buy |
367,357
+247,234
| +206% | +$2.78M | ﹤0.01% | 2338 |
|
|
2023
Q2 | $399K | Sell |
120,123
-3,734
| -3% | -$12.4K | ﹤0.01% | 3151 |
|
|
2023
Q1 | $489K | Hold |
123,857
| – | – | ﹤0.01% | 2958 |
|
|
2022
Q4 | $898K | Sell |
123,857
-3,252
| -3% | -$23.6K | ﹤0.01% | 2807 |
|
|
2022
Q3 | $461K | Buy |
127,109
+331
| +0.3% | +$1.2K | ﹤0.01% | 3026 |
|
|
2022
Q2 | $575K | Buy |
126,778
+102,467
| +421% | +$465K | ﹤0.01% | 3020 |
|
|
2022
Q1 | $185K | Hold |
24,311
| – | – | ﹤0.01% | 3319 |
|
|
2021
Q4 | $266K | Hold |
24,311
| – | – | ﹤0.01% | 3305 |
|
|
2021
Q3 | $315K | Buy |
+24,311
| New | +$315K | ﹤0.01% | 3255 |
|